CRP and COVID-19: Talavera et al. (40) found that COVID-19 patients with anosmia, compared to those without anosmia, presented a higher prevalence of headache and lower severity and mortality rate, and also higher values of lymphocyte count, increased glomerular filtration rate, and lower CRP levels.